Zuhair Mir Ali, MD | |
1429 Highway 6 Ste 206, Sugar Land, TX 77478-5135 | |
(832) 500-1350 | |
Not Available |
Full Name | Zuhair Mir Ali |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 7 Years |
Location | 1429 Highway 6 Ste 206, Sugar Land, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710477039 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | T6171 (Texas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hillcroft Medical Clinic Assoc | 8527056068 | 36 |
News Archive
Lithocholic acid (LCA), naturally produced in the liver during digestion, has been seriously underestimated. A study published in the journal Oncotarget shows that LCA can kill several types of cancer cells, such as those found in some brain tumors and breast cancer.
EvaluatePharma, the premier provider of pharmaceutical and biotech analysis including consensus forecasts, today released its World Preview 2018 report, providing an in-depth look at how the patent cliff will reshape the drug industry over the next six years — with valuable insight into which companies and products will come out as winners.
Today's headlines include a range of stories about the implementation of the health law and related policy developments.
GlaxoSmithKline has announced that the United States Food and Drug Administration (FDA) granted accelerated approval for PROMACTA (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
› Verified 7 days ago
Entity Name | Hillcroft Medical Clinic Assoc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588605430 PECOS PAC ID: 8527056068 Enrollment ID: O20040504000707 |
News Archive
Lithocholic acid (LCA), naturally produced in the liver during digestion, has been seriously underestimated. A study published in the journal Oncotarget shows that LCA can kill several types of cancer cells, such as those found in some brain tumors and breast cancer.
EvaluatePharma, the premier provider of pharmaceutical and biotech analysis including consensus forecasts, today released its World Preview 2018 report, providing an in-depth look at how the patent cliff will reshape the drug industry over the next six years — with valuable insight into which companies and products will come out as winners.
Today's headlines include a range of stories about the implementation of the health law and related policy developments.
GlaxoSmithKline has announced that the United States Food and Drug Administration (FDA) granted accelerated approval for PROMACTA (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
› Verified 7 days ago
Entity Name | Questcare Hospitalists Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265441620 PECOS PAC ID: 5799785119 Enrollment ID: O20070109000581 |
News Archive
Lithocholic acid (LCA), naturally produced in the liver during digestion, has been seriously underestimated. A study published in the journal Oncotarget shows that LCA can kill several types of cancer cells, such as those found in some brain tumors and breast cancer.
EvaluatePharma, the premier provider of pharmaceutical and biotech analysis including consensus forecasts, today released its World Preview 2018 report, providing an in-depth look at how the patent cliff will reshape the drug industry over the next six years — with valuable insight into which companies and products will come out as winners.
Today's headlines include a range of stories about the implementation of the health law and related policy developments.
GlaxoSmithKline has announced that the United States Food and Drug Administration (FDA) granted accelerated approval for PROMACTA (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Zuhair Mir Ali, MD 1110 Mulberry Farm Ln, Richmond, TX 77469-7382 Ph: (832) 567-9185 | Zuhair Mir Ali, MD 1429 Highway 6 Ste 206, Sugar Land, TX 77478-5135 Ph: (832) 500-1350 |
News Archive
Lithocholic acid (LCA), naturally produced in the liver during digestion, has been seriously underestimated. A study published in the journal Oncotarget shows that LCA can kill several types of cancer cells, such as those found in some brain tumors and breast cancer.
EvaluatePharma, the premier provider of pharmaceutical and biotech analysis including consensus forecasts, today released its World Preview 2018 report, providing an in-depth look at how the patent cliff will reshape the drug industry over the next six years — with valuable insight into which companies and products will come out as winners.
Today's headlines include a range of stories about the implementation of the health law and related policy developments.
GlaxoSmithKline has announced that the United States Food and Drug Administration (FDA) granted accelerated approval for PROMACTA (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
› Verified 7 days ago
Monica Kalra, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14023 Southwest Fwy, Sugar Land, TX 77478 Phone: 281-325-4100 | |
Dr. Brent Devin Reed, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15200 Southwest Fwy Ste 175, Sugar Land, TX 77478 Phone: 713-461-2915 Fax: 713-461-5307 | |
Robbyn Lucille Traylor, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2415 Town Center Dr, Ste 300, Sugar Land, TX 77478 Phone: 281-201-0657 | |
Dr. Cedela Abdulla, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3533 Town Center Blvd S, Ste. 200, Sugar Land, TX 77479 Phone: 713-772-0793 Fax: 281-781-2557 | |
Wyntria Lacabe-moore, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1403 Highway 6, Sugar Land, TX 77478 Phone: 832-260-0640 | |
Dr. Abraham K. Peringol, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 14815 Southwest Fwy, Sugar Land, TX 77478 Phone: 281-565-2140 Fax: 281-565-2174 | |
Owen Capocyan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4911 Sandhill Dr, Sugar Land, TX 77479 Phone: 816-334-9302 |